1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Corticospinal tract (CST) volumes in patients with amyotrophic lateral sclerosis (ALS) and healthy subjects
Measurement Healthy Control Subjects (n = 17) ALS Patients (n = 16) Left (10−3 mm3) Right (10-3 mm3) Affected (10−3 mm3) Nonaffected (10−3 mm3) CST volume (mean ± SD) 10.19 ± 0.94 10.43 ± 0.96 9.18 ± 0.70* 9.33 ± 0.64*
* Statistically different by unpaired t-test (P < .01).